Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $850.03 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $208.77 | 12 | $0 (2022) |
| Novo Nordisk Inc | $102.50 | 6 | $0 (2024) |
| ABBVIE INC. | $98.79 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.80 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $71.70 | 5 | $0 (2022) |
| Medtronic, Inc. | $56.48 | 3 | $0 (2024) |
| Lilly USA, LLC | $53.51 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $51.18 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $31.91 | 2 | $0 (2023) |
| Dexcom, Inc. | $18.80 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126.12 | 7 | Novo Nordisk Inc ($38.98) |
| 2023 | $134.25 | 7 | Medtronic, Inc. ($34.60) |
| 2022 | $529.90 | 31 | AstraZeneca Pharmaceuticals LP ($179.62) |
| 2021 | $59.76 | 4 | AstraZeneca Pharmaceuticals LP ($29.15) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Gastroenterology | ||||||
| 03/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: GI | ||||||
| 02/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/02/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/14/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, SHINGRIX | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: VACCINES | ||||||
| 03/01/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/08/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 08/31/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/18/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 08/16/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/14/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/11/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Respiratory | ||||||
| 07/01/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 06/30/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 200 | 307 | $17,349 | $7,920 |
| 2022 | 17 | 910 | 1,251 | $73,913 | $34,005 |
| 2021 | 12 | 387 | 517 | $27,576 | $16,443 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 79 | $10,270 | $5,935 | 57.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 21 | 21 | $1,365 | $717.55 | 52.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 29 | 31 | $1,240 | $489.67 | 39.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 44 | $1,672 | $333.34 | 19.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 21 | $252.00 | $152.72 | 60.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 17 | 19 | $475.00 | $134.72 | 28.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 13 | 15 | $600.00 | $113.50 | 18.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 13 | $195.00 | $26.26 | 13.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 64 | $1,280 | $17.03 | 1.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 305 | $39,650 | $20,473 | 51.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 98 | 110 | $7,980 | $4,739 | 59.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 118 | 134 | $5,360 | $2,186 | 40.8% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2022 | 64 | 143 | $5,005 | $1,987 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $3,610 | $1,335 | 37.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 27 | 54 | $1,890 | $893.70 | 47.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 46 | 51 | $2,040 | $423.72 | 20.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 50 | 55 | $1,375 | $419.82 | 30.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 29 | $1,305 | $391.12 | 30.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 48 | $1,824 | $323.79 | 17.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 44 | 48 | $1,008 | $241.16 | 23.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 11 | 11 | $550.00 | $198.11 | 36.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 60 | $720.00 | $176.57 | 24.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 45 | 48 | $720.00 | $148.23 | 20.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 14 | 14 | $168.00 | $49.88 | 29.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 15 | 58 | $580.00 | $13.48 | 2.3% |
About Candice Parish, FNP-C
Candice Parish, FNP-C is a Family healthcare provider based in Kosciusko, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2020. The National Provider Identifier (NPI) number assigned to this provider is 1659905271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Candice Parish, FNP-C has received a total of $850.03 in payments from pharmaceutical and medical device companies, with $126.12 received in 2024. These payments were reported across 49 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($850.03).
As a Medicare-enrolled provider, Parish has provided services to 1,497 Medicare beneficiaries, totaling 2,075 services with total Medicare billing of $58,367. Data is available for 3 years (2021–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Kosciusko, MS
- Active Since 02/24/2020
- Last Updated 11/17/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1659905271
Products in Payments
- BREZTRI (Drug) $153.59
- FARXIGA (Drug) $55.18
- Rybelsus (Drug) $51.72
- Ozempic (Drug) $50.78
- STIOLTO RESPIMAT (Drug) $46.13
- LEQVIO (Drug) $43.84
- INTELLIS ADAPTIVESTIM (Device) $41.91
- MOUNJARO (Drug) $39.72
- BELSOMRA (Drug) $35.26
- UBRELVY (Drug) $35.03
- OFEV (Drug) $31.67
- CREON (Drug) $29.06
- ENTRESTO (Drug) $27.86
- Dexcom G6 Transmitter (Medical Supply) $18.80
- Linzess (Drug) $18.76
- QULIPTA (Drug) $18.56
- TRELEGY ELLIPTA (Drug) $16.93
- Kerendia (Drug) $16.71
- LINZESS (Drug) $16.14
- GARDASIL 9 (Biological) $15.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Kosciusko
Mr. Timothy South, Fnp, FNP
Family — Payments: $4,999
Robert Greenlee, Fnp, FNP
Family — Payments: $2,751
Meagan Carpenter, Fnp, FNP
Family — Payments: $1,641
Kayla Ferguson, Fnp-C, FNP-C
Family — Payments: $606.75
Mrs. Linda Cockroft, Fnp, FNP
Family — Payments: $217.54
Allison Langford, Fnp, FNP
Family — Payments: $186.26